NPPB and cardiac hypertrophy: The anti-hypertrophic effect of SFN-F-EXOs is supported by a considerable reduction in BNP gene expression in AngII-stressed cardiomyocytes, where levels rise in proportion to the degree of myocardial hypertrophy [67].